| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5615102 | Journal of Clinical Lipidology | 2017 | 34 Pages |
Abstract
The presence of MS was not associated with worse CV outcomes in the AIM-HIGH population. The rate of CV events in statin-treated Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes patients with MS was not significantly influenced by the number of MS components.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Radmila MD, Jennifer G. MD, MPH, Michael MD, Debra L. MD, Ping MS, Beth L. MD, Marshall B. MD, PhD, Todd M. MD, Ruth ScB, Jerome L. MD, Patrice MD, Woubeshet MD, William E. MD,